The opt-out deadline for Bayer's proposed $7.25 billion Roundup class action settlement passed on June 4, 2026, marking a critical procedural milestone in one of the most significant mass tort resolutions in recent memory. With the final approval hearing now scheduled for July 9, 2026 before a Missouri judge, claimants and their counsel must promptly evaluate where they stand and what options remain available. The settlement received preliminary approval on March 4, 2026, setting in motion a compressed timeline that has left many class members weighing complex strategic decisions under considerable time pressure.
If finally approved, the settlement would resolve tens of thousands of lawsuits alleging that glyphosate-based Roundup caused non-Hodgkin lymphoma. Individual compensation under the proposed framework ranges from approximately $6,000 to $165,000 or more, with awards calibrated to factors such as documented exposure history and the severity of a claimant's diagnosis. For many affected individuals and families, the prospect of streamlined compensation offers a measure of certainty that has been elusive throughout years of contested litigation against Bayer.
That certainty, however, is now clouded by newly filed constitutional challenges to the structure of the deal itself. These objections raise the prospect that final approval could be delayed, modified, or potentially disrupted altogether, leaving both class members and those who elected to opt out in a state of meaningful uncertainty. Claimants who remained in the class will need to monitor developments closely as the July 9 hearing approaches, while those who opted out must begin or continue preparing their individual cases on the assumption that they will proceed independently.
The intersection of a passed opt-out deadline, pending constitutional objections, and a fast-approaching final approval hearing creates a particularly fluid landscape. Counsel representing affected individuals should be assessing claim documentation, exposure records, and medical evidence now, regardless of whether their clients remain in the class or have elected to litigate separately. Strategic clarity in the coming weeks will be essential as the court weighs both the fairness of the proposed settlement and the merits of the constitutional challenges before it.
This article is provided for general informational purposes only. Individuals affected by Roundup litigation should consult qualified counsel to obtain advice tailored to their specific circumstances.